Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] Samsung Biologics (207940) – Kiwoom Securities | Plant 6 Groundbreaking Visibility · Labor Negotiation · Rockville Revenue Recognition / 2026-04-02 Research
  • [Research] Alteogen (196170) – Shinhan Securities | 2 Out-Licensing Deals in Q1 · Biogen Deal Analysis · Major Catalysts Ahead from April / 2026-03-27 Research
  • [Research] Samsung Electro-Mechanics (009150) – iM Securities | Silicon Capacitor LTA · Fabless Model · SOTP Re-rating / 2026-05-21 Research
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | Commodity Memory Pricing · HBM4 · Valuation Appeal / 2026-07-30 Research
  • [IR] SK hynix (000660 / SKHY) – Q4 2023 Earnings Presentation / 2024-01-25 IR Room
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Hyperscaler Capex · Custom HBM · Inference Memory Demand / 2026-05-04 Research
  • [Research] LIG D&A (079550/KS) – SK Securities | 1Q26 Earnings Beat · Overdone Correction · Global Demand Expansion / 2026-05-08 Research
  • [Research] Hanwha Ocean (042660) – Eugene | High-Price Order Mix · Merchant Margin Continuity · Special Ship Pipeline / 2026-07-28 Research

[Research] SK hynix (000660 / SKHY) – SK Securities | LTA · Capex Discipline · Cycle Stability / 2026-01-28

Posted on January 28, 2026August 24, 2026 By ksb220805@gmail.com

Market: KOSPI (000660)

Brokerage : SK Securities

Analyst : Donghee Han

Investment Rating : BUY (Maintained)

Target Price : 1,500,000 KRW (Raised)

Core Momentum : An LTA-driven order-first supply structure combined with disciplined capacity expansion is expected to prolong memory shortages and reduce traditional cycle volatility, supporting record profitability and structurally higher earnings visibility.

📊 1. [Valuation & Key Financial Metrics]

  • Target Price: 1,500,000 KRW (Based on Target P/E 9.0X applied to 2026E EPS of 160,368 KRW, 50% Raised)
  • Investment Rating: BUY (Maintained)
  • 2026E Financial Outlook: Revenue 205.15 trillion KRW, Operating Profit 147.22 trillion KRW, Net Income 116.75 trillion KRW
  • EPS: 160,368 KRW (2026E)
  • Valuation Multiples: PER 5.0x, PBR 2.5x, EV/EBITDA 2.8x, ROE 67.4% (Based on 2026E)

🚀 2. [Market Opportunities & Business Outlook]

  • Upgraded Industry Projections: Reflecting stronger-than-expected memory market conditions, 2026E memory price increase forecasts are revised upward to +71% for DRAM and +83% for NAND.
  • Earnings Outlook: Operating profit for 2026 is projected to reach 147 trillion KRW (+213% YoY) with an operating margin of 72%, setting all-time highs in both earnings and profitability, exceeding market consensus operating profit by 34%.
  • Structural Shift: The memory industry is transitioning into an “order-first, expansion-later” structure anchored by long-term contracts (LTAs), breaking away from traditional cyclicality. Amid sustained CapEx discipline and space constraints, supply shortages are compounding across all product lines including HBM3E/4, generic DRAM, and SSDs.
  • Cash Flow Deployment: Accumulated robust cash flows will be utilized for shareholder returns, contract-based facility investments, and M&As to enhance corporate value.

📝 Editor’s Comment (Perspective)

The analyst views SK hynix as transcending traditional cyclical limitations through an LTA-anchored “order-first, expansion-later” framework, supported by ongoing CapEx discipline and spatial constraints. The analyst emphasizes that peak-out concerns are merely cyclical rhetoric, and attention should instead focus on valuation expansion propelled by supply constraints and strong cash generation.

To verify this investment thesis, one should track whether actual 2026 memory price increases meet the revised projections (DRAM +71%, NAND +83%), if optimized LTA weightings and supply structures translate into stable earnings growth, and how cumulative cash flows effectively result in enhanced shareholder returns and corporate value-up initiatives. These indicators can be monitored through upcoming quarterly reports and regulatory filings via DART.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

Post navigation

Previous Post: [Research] LigaChem Biosciences (141080) – Mirae Asset Securities | Clinical Readouts · Pipeline Valuation · SOTP / 2026-01-26
Next Post: [IR] SK hynix (000660 / SKHY) – Q4 2025 Earnings Presentation / 2026-01-29

Related Posts

  • [Research] Alteogen (196170) – Shinhan Securities | Halozyme Patent Invalidated · Key Overhangs Materially Eased · Target Price Raised / 2026-05-14 Research
  • [Research] SK hynix (000660 / SKHY) – Shinhan | Memory ASP · Supply Tightness · Pricing Power / 2026-01-30 Research
  • [Research] Samsung SDI (006400) – DS Investment & Securities | Core Profitability Turnaround · Robust ESS Backlog · Humanoid Physical AI Expansion / 2026-07-31 Research
  • [Research] Samsung Biologics (207940) – DS Investment & Securities | Order Recovery · Plant Ramp-up · Earnings Growth / 2026-07-24 Research
  • [Research] SK hynix (000660 / SKHY) – Eugene Investment | HBM Demand · AI Accelerator Diversification · Profitability / 2026-01-21 Research
  • [Research] LIG D&A (079550) – SK Securities | CapEx Expansion · Global Interceptor Shortage · Earnings Quality / 2026-08-10 Research
  • [IR] Samsung Electro-Mechanics (009150) – Q2 2025 Earnings Presentation / 2025-07-31 IR Room
  • [Research] Samsung Electro-Mechanics (009150) – Shinhan Securities | Silicon Capacitor · ASP Expansion · Valuation Re-rating / 2026-05-26 Research
  • [Research] LIG D&A (079550) – Kiwoom Securities | Order Visibility · Production Expansion · Middle East Deliveries / 2026-08-07 Research
  • [Research] Samsung SDI (006400) – SK Securities | Plant Utilization Recovery · North America ESS Expansion · AMPC Benefits / 2026-04-29 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | AI Data Center Backlogs · LTA · Earnings Visibility / 2026-05-11 Research
  • [Research] ABL Bio (298380) – Kyobo Securities | ABL001 Clinical Data · Market Overreaction · Grabody-B Potential / 2026-04-29 Research
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | Capacity Cannibalization · 1-Year LTA · Pricing Power / 2026-07-06 Research
  • [Research] SK hynix (000660 / SKHY) – Meritz | ADR Listing · Valuation Discount · Re-rating / 2026-04-23 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme